OOIR: Observatory of International Research

Papers

(The H4-Index of Multiple Sclerosis and Related Disorders is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Test-retest reliability of the Swedish version of the Modified Fatigue Impact Scale in people with mild to moderate multiple sclerosis	75
Preliminary race-ethnicity-based analyses of fall risk among people with multiple sclerosis	61
Characteristics of Patients with Newly Diagnosed Multiple Sclerosis: A Five-Year Study at Benghazi Medical Center, Benghazi, Libya	60
Real-World Evidence with Five-Year Data (2017-2022) on the Use of Cladribine Tablets in Patients with Multiple Sclerosis in England: an Updated Analysis from the CLARENCE Study	59
EDSS and Infratentorial White Matter Lesion Volume are Considered Predictors of Fatigue Severity in RRMS	53
Influence of Cigarette, and Waterpipe Smoking, Alcohol, and Drug Consumption on the Occurrence of Late-Onset Multiple Sclerosis	49
Comparison of SARS-CoV-2 antibody response after two doses of mRNA and inactivated vaccines in multiple sclerosis patients treated with disease-modifying therapies	48
A one year follow of patients with multiple sclerosis during COVID-19 pandemic: A cross-sectional study in Qom province, Iran	47
Markers of Epstein-Barr virus and Human Herpesvirus-6 infection and multiple sclerosis clinical progression	47
Evaluation of adherence to treatment in patients with multiple sclerosis from Latin America	46
Plasma 24-hydroxycholesterol is associated with narrower common carotid artery and greater flow velocities in relapsing multiple sclerosis	41
“It's on the tip of my tongue!” exploring confrontation naming difficulties in patients with multiple sclerosis	41
Diagnosing ‘transition’ to secondary progressive multiple sclerosis (SPMS): A step-by-step approach for clinicians	41
Peripheral nerve vulnerability as risk factor for multiple sclerosis: Possible insights from Neurofibromatosis type 2 (NF2)	40
Leber Hereditary Optic Neuropathy Presenting as Bilateral Visual Loss and White Matter Disease	40
Involvement Peripheral Nerve System in Multiple Sclerosis	40
The Use of Ocrelizumab in Pediatric Multiple Sclerosis Patients in the United Arab Emirates: A Retrospective Study	38
The Relationship Between Smoking and Multiple Sclerosis Severity in Saudi Arabia	37
Effects of constraint induced movement therapy in patients with multiple sclerosis: A systematic review	37
Risk factors for development of lymphopenia in dimethyl fumarate-treated patients with multiple sclerosis	36
Clinical and imaging features of patients with late-onset myelin oligodendrocyte glycoprotein antibody-associated disease	35
Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets	35
Index of cardiac-electrophysiological balance in relapsing–remitting multiple sclerosis patients treated with fingolimod	34
Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in Italy	34
Functional electrical stimulation combined with voluntary cycling accentuates VO2 response in people with severe multiple sclerosis: A pilot study	34

Characteristics of recurrence risk perception and coping strategies in patients with neuromyelitis optica spectrum disorder: A qualitative study	34
Reconciling lesions, relapses and smouldering associated worsening: A unifying model for multiple sclerosis pathogenesis	34
Trait mindfulness, emotion dysregulation, and depression in individuals with multiple sclerosis	34
Coexistence of epilepsy or seizure and multiple sclerosis; a single center experience	34
Impact of insurance status on MRI phenotypes in MS	33
143. Navigating the Maze of Multiple Sclerosis Disease Modifying Therapies: Insights from Iran's National MS Registry	33
57. Cognitive Decline and Motor Handicap in Multiple Sclerosis Patients	33
Lipid measures are associated with cognitive functioning in multiple sclerosis patients	32
125. Investigating Psychoses in Pediatric-Onset Multiple Sclerosis: A Systematic Review of Case Reports	32
157. Remibrutinib Exposure in Cerebrospinal Fluid: Insights from a Study in Healthy Subjects	32